Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonazoid for Liver Pathology Evaluation in Patients with CT/MRI Contraindications
NCT02651090Phase 3Withdrawn
- Sponsor
- Northeastern Ohio Radiology Research and Education Fund
- Start
- Oct 2017
- Primary completion
- Mar 2018
- Modality
- Nanoparticles
01
Overview
A Phase 3 trial of sonazoid in liver metastasis, hepatic neoplasm, sponsored by Northeastern Ohio Radiology Research and Education Fund. Planned start Oct 2017; status: withdrawn.
02
Drugs
sonazoid
03
Conditions
liver metastasishepatic neoplasm
Beyond the preview
Go deeper on NCT02651090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02651090.